SAB Biotherapeutics Inc

NASDAQ:SABS   3:59:51 PM EDT
10.39
-0.85 (-7.56%)
Earnings Announcements

Sab Biotherapeutics Reports Q3 Financial Results

Published: 11/22/2021 12:13 GMT
SAB Biotherapeutics Inc (SABS) - Sab Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Company Update.
Revenue is expected to be $15 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $15.53 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.